Intercept Pharmaceuticals Inc (ICPT)
37.27
-0.12 -0.32%
NASDAQ
Nov 27, 20:00
USD
Intercept Pharmaceuticals Gross Profit Margin (Quarterly):
97.70% for Sept. 30, 2020View 4,000+ financial data types
Browse...
View Full Chart
Gross Profit Margin (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Gross Profit Margin (Quarterly) Data
View and export this data going back to 2017.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Sept. 30, 2020 | 97.70% |
| June 30, 2020 | 97.57% |
| March 31, 2020 | 98.83% |
| Dec. 31, 2019 | 96.54% |
| Sept. 30, 2019 | 99.21% |
| June 30, 2019 | 98.98% |
| March 31, 2019 | 98.90% |
| Dec. 31, 2018 | 98.11% |
| Sept. 30, 2018 | 98.90% |
| June 30, 2018 | 98.36% |
| March 31, 2018 | 99.22% |
| Dec. 31, 2017 | 97.82% |
| Sept. 30, 2017 | 99.58% |
| June 30, 2017 | 99.10% |
| March 31, 2017 | 99.54% |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Benchmarks
| Zosano Pharma Corp | -- |
| Biomarin Pharmaceutical Inc | 60.40% |
| Celsion Corp | -- |
Gross Profit Margin (Quarterly) Range, Past 5 Years
| Minimum | 96.54% | Dec 2019 |
| Maximum | 99.58% | Sep 2017 |
| Average | 98.56% |
News
Advertisement
